Exelis reports third-quarter 2014 financial results; revises full-year guidance
[ Back ]   [ More News ]   [ Home ]
Exelis reports third-quarter 2014 financial results; revises full-year guidance

MCLEAN, Va. — (BUSINESS WIRE) — October 31, 2014 — Exelis ( NYSE: XLS) reported financial results for the third quarter of 2014. Third-quarter revenue was $1.1 billion, a six percent decrease from the third quarter of 2013, and third-quarter earnings were $52 million, or $0.27 per diluted share, a 34 percent decrease from the third quarter of 2013. Adjusted earnings, which exclude costs related to the spin-off of Vectrus, were $0.32 per share, a 22 percent decrease from the same period in 2013. Exelis generated $39 million in free cash flow during the quarter.

The company earned $1.5 billion in funded orders during the third quarter of 2014, including new business in its strategic growth platforms. Key announcements during the quarter included:

“We are encouraged by the developing trend of revenue growth in our C4ISR segment and continue to earn new business in each of our strategic growth platforms, as well as from targeted international and commercial customers,” said Exelis CEO and President David F. Melcher. “Successful completion of the Vectrus spinoff was also a major milestone for us in the third quarter and positions both companies for success in the future.”

Segment Results

C4ISR Electronics and Systems

C4ISR Electronics and Systems third-quarter 2014 revenue was $503 million, up 1 percent from the same period in 2013 due to higher revenue on airborne and shipboard electronic warfare products, partially offset by lower revenue from domestic radios. Segment adjusted operating income for the quarter was $64 million, a decrease of 7 percent from the third quarter of 2013.

Information and Technical Services

Information and Technical Services third-quarter 2014 revenue was $565 million, a decrease of 12 percent from the same period in 2013, driven by lower customer activity in several U.S. government programs in Afghanistan. Third-quarter adjusted operating income for the segment was $47 million, down 27 percent from the same period in 2013, primarily due to lower revenue.

2014 Guidance

       
Sales     ≈$3.25 billion
Adjusted Operating Margin     ≈12.5%
Adjusted Earnings Per Share     ≈$1.22
Free Cash Flow     ≈$140 million
   

Exelis is adjusting its 2014 financial guidance to account for the spin-off of Vectrus, which was completed on September 27, 2014. Financial guidance includes approximately $15 million of projected restructuring expense and excludes approximately $25 million of expenses related to the spin-off of Vectrus. The company notes that forward-looking statements of future performance made in this release are based upon current expectations and are subject to factors that could cause actual results to differ materially from those suggested here, including those factors set forth in the Safe Harbor Statement below.

Investor Call Today

Exelis senior management will host a conference call for investors today at 10 a.m. EDT to review third-quarter 2014 results and guidance, and answer questions. The briefing can be monitored live via webcast at the following address on the company's website: http://investors.exelisinc.com.

About Exelis

Exelis is a diversified, global, aerospace, defense and information solutions company that leverages a 50-year legacy of deep customer knowledge and technical expertise to deliver affordable, mission-critical solutions for global customers. We are a leader in positioning and navigation, sensors, air traffic management solutions, image processing and distribution, communications and information systems, and focused on strategic growth in the areas of critical networks, ISR and analytics, electronic warfare and composite aerostructures. Headquartered in McLean, Va., Exelis employs approximately 10,000 people and generated 2013 sales of $4.8 billion. For more information, visit our website at  www.exelisinc.com or connect with us on  FacebookTwitterLinkedIn and  YouTube.

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 (the “Act”): Some of the information included herein includes forward-looking statements intended to qualify for the safe harbor from liability established by the Act. Whenever used, words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “target,” “may,” “could,” “outlook” and other terms of similar meaning are intended to identify such forward-looking statements. Forward-looking statements are uncertain and to some extent unpredictable, and involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from those expressed in, or implied from, such forward-looking statements. The company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from the company’s historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to:

The forward-looking statements in this release are made as of the date hereof and the company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from the company’s historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in the Exelis Inc. Form 10-K for the fiscal year ended December 31, 2013, and those described from time to time in our future reports filed with the Securities and Exchange Commission.

               
Exelis Inc.
Consolidated Statements of Operations
(unaudited)
 
(IN MILLIONS, EXCEPT PER SHARE AMOUNTS)

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

      2014     2013     2014     2013
Product revenue $ 503 $ 498 $ 1,506 $ 1,515
Service revenue       565       643       1,724       2,062
Total revenue       1,068       1,141       3,230       3,577
Cost of product revenue 356 354 1,088 1,091
Cost of service revenue 477 537 1,456 1,708
Selling, general and administrative expenses 117 100 344 337
Research and development expenses 18 11 43 39
Restructuring and asset impairment charges       4       6       11       68
Operating income 96 133 288 334
Interest expense, net 9 10 27 28
Other (income) expense, net       (1)       3       (5)       2
Income from continuing operations before income tax expense 88 120 266 304
Income tax expense       36       40       101       102
Net income     $ 52     $ 80     $ 165     $ 202
Earnings Per Share
Basic
Net income $ 0.28 $ 0.42 $ 0.87 $ 1.07
Diluted
Net income $ 0.27 $ 0.41 $ 0.85 $ 1.06
Weighted average common shares outstanding – basic 188.4 188.5 189.0 188.3
Weighted average common shares outstanding – diluted 193.2 192.8 193.9 191.0
Cash dividends declared per common share     $ 0.10     $ 0.10     $ 0.31     $ 0.31
 

     
Exelis Inc.
Consolidated Balance Sheets
(unaudited)
 
 
(IN MILLIONS) September 30, December 31,
        2014     2013
Assets
Current assets
Cash and cash equivalents $ 524 $ 469
Receivables, net 939 939
Inventories, net 258 246
Deferred tax asset 44 16
Other current assets       42       70  
Total current assets       1,807       1,740  
Plant, property and equipment, net 452 498
Goodwill 2,195 2,184
Other intangible assets, net 157 167
Deferred tax asset 186 216
Other non-current assets       120       79  
Total non-current assets       3,110       3,144  
Total assets     $ 4,917     $ 4,884  
Liabilities and Shareholders' Equity
Current liabilities
Accounts payable $ 311 $ 367
Advance payments and billings in excess of costs 266 301
Compensation and other employee benefits 183 216
Other accrued liabilities       173       160  
Total current liabilities       933       1,044  
Defined benefit plans 1,259 1,407
Long-term debt 778 649
Deferred tax liability 3 2
Other non-current liabilities       155       130  
Total non-current liabilities       2,195       2,188  
Total liabilities       3,128       3,232  
Commitments and contingencies
Shareholders' equity
Common stock 2 2
Additional paid-in capital 2,660 2,623
Treasury stock

(69

)

(16

)

Retained earnings 580 475
Accumulated other comprehensive loss       (1,384 )     (1,432 )
Total shareholders' equity       1,789       1,652  
Total liabilities and shareholders' equity     $ 4,917     $ 4,884  
 

       
Exelis Inc.
Consolidated Statements of Cash Flows
(unaudited)
 
 
(IN MILLIONS) Nine Months Ended September 30,
      2014     2013
Operating activities
Net income $ 165 $ 202
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 88 85
Stock-based compensation 21 25
Restructuring and asset impairment charges 11 68
Payments for restructuring (23) (42)
Defined benefit plans expense 48 69
Defined benefit plans payments (134) (136)
Change in assets and liabilities
Change in receivables 1 (22)
Change in inventories (10) (4)
Change in other assets 9 (5)
Change in accounts payable (56) (93)
Change in advance payments and billings in excess of costs (35) 13
Change in deferred taxes (14) 31
Change in other liabilities 2 (73)
Other, net       (2)      
Net cash provided by operating activities       71       118
Investing activities
Capital expenditures (37) (57)
Proceeds from the sale of assets 4 9
Acquisitions, net of cash acquired (22) (16)
Other, net       (1)      
Net cash used in investing activities       (56)       (64)
Financing activities
Proceeds from issuance of debt 140
Payment of debt issuance costs (4)
Dividends paid (60) (39)
Common stock repurchased (53) (5)
Proceeds from exercise of stock options 17 11
Other, net       2       (2)
Net cash provided by (used in) financing activities       42       (35)
Exchange rate effects on cash and cash equivalents       (2)       (2)
Net change in cash and cash equivalents 55 17
Cash and cash equivalents – beginning of year       469       292
Cash and cash equivalents – end of period     $ 524     $ 309
 

 
Key Performance Indicators and Non-GAAP Financial Measures
 
Management reviews key performance indicators including revenue, segment operating income and margins, orders growth, and backlog, among other metrics on a regular basis. In addition, we consider certain additional measures to be useful to management and investors evaluating our operating performance for the periods presented, and provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including, but not limited to, acquisitions and debt repayment. These metrics, however, are not measures of financial performance under accounting principles generally accepted in the United States of America (GAAP) and should not be considered a substitute for revenue, operating income, income from continuing operations, or net cash from continuing operations as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators:
 

“Adjusted net income” defined as net income, adjusted to exclude items that include, but are not limited to, significant charges or credits that impact current results, but are not related to our ongoing operations, unusual and infrequent non-operating items and non-operating tax settlements or adjustments.

 

“Segment adjusted operating income” defined as operating income of our two segments, adjusted to exclude items that include, but are not limited to, significant charges or credits that impact current results, but are not related to our ongoing operations, unusual and infrequent non-operating items and non-operating tax settlements or adjustments.

 

“Segment adjusted operating margin” defined as segment adjusted operating income as defined above, divided by revenue.

 
“Free cash flow” defined as GAAP cash provided by operating activities, less capital expenditures plus separation costs related to the spin-off of Mission Systems. This metric does not include dividend payments.
 
“Estimated adjusted net income excluding Vectrus” defined as adjusted net income as defined above adjusted to exclude estimated Vectrus results and give effect to spin-related estimated G&A/tax adjustments.
 
“Estimated adjusted operating income excluding Vectrus" defined as adjusted operating income as defined above adjusted to exclude estimated Vectrus results and give effect to spin-related estimated G&A/tax adjustments.
 
“Estimated adjusted operating margin excluding Vectrus" defined as estimated adjusted operating income as defined above adjusted to exclude estimated Vectrus results and give effect to spin-related estimated G&A/tax adjustments.
 
“Estimated adjusted free cash flow excluding Vectrus" defined as free cash flow as defined above adjusted to exclude estimated Vectrus results and give effect to spin-related estimated G&A/tax adjustments.
 

       
Exelis Inc.
Non-GAAP Financial Measures - Adjusted Net Income & Adjusted EPS
 
Three Months Ended Nine Months Ended
September 30, September 30,
($ million, except per share)   2014   2013 2014   2013
Net Income 52 80 165 202
               
Separation Costs for the Vectrus Spin-off, net of tax   9   - 19   -
Adjusted Net Income   61   80 184   202
               
Net Income per fully diluted share $0.27 $0.41 $0.85 $1.06
Adjusted Net Income per fully diluted share   $0.32   $0.41 $0.95   $1.06
 
Weighted Average Shares Outstanding, Diluted 193.2 192.8 193.9 191.0
 

         
Exelis Inc.
Non-GAAP Financial Measures - Adjusted Segment Operating Income & Operating Margin
 
Three Months Ended

Nine Months Ended

September 30,

September 30,

($ million)   2014   2013 2014   2013
Sales 1,068 1,141 3,230 3,577
C4ISR 503 498 1,506 1,515
I&TS 565 643 1,724 2,062
               
Segment Operating Income, As Reported 96 133 288 334
C4ISR 59 69 162 128
I&TS   37   64 126   206
               
Separation Costs for the Vectrus Spin-off, pre tax 15 - 30 -
C4ISR 5 - 13 -
I&TS   10   - 17   -
               
Segment Operating Income, Adjusted 111 133 318 334
C4ISR 64 69 175 128
I&TS   47   64 143   206
               
Segment Operating Margin, As Reported
C4ISR 11.7% 13.9% 10.8% 8.4%
I&TS   6.5%   10.0% 7.3%   10.0%
               
Segment Operating Margin, Adjusted

 

 

 

 

C4ISR 12.7% 13.9% 11.6% 8.4%
I&TS   8.3%   10.0% 8.3%   10.0%
               
Operating Margin, As Reported 9.0% 11.7% 8.9% 9.3%
Operating Margin, Adjusted   10.4%   11.7% 9.8%   9.3%
 

   
Exelis Inc.
Free Cash Flow Year-to-Date
 
Nine Months Ended Nine Months Ended
September 30,   September 30,
($ million)   2014   2013
Cash Flow From Operating Activities   71   118
 
Subtract:        
Capital Expenditures   (37)   (57)
Free Cash Flow   34   61
 
Add:        
Separation Costs for the Mission Systems Spin-off, net of tax   19   -
Free Cash Flow, as Adjusted   53   61
 

     
Exelis Inc.
Free Cash Flow Quarter-to-Date
 
 
Three Months Ended Nine Months Ended Six Months Ending
September 30,

September 30,

  June 30,
($ million)   2014 2014   2014
Cash Flow From Operating Activities   49 71   22
 
Subtract:          
Capital Expenditures   (19) (37)   (18)
Free Cash Flow   30 34   4
 
Add:          
Separation Costs for the Mission Systems Spin-off, net of tax   9 19   10
Free Cash Flow, as Adjusted   39 53   14
 

         
Exelis Inc.
Non-GAAP Financial Measures - Adjusted Net Income & Adjusted EPS Excluding Vectrus Results
 
Three Months Ended Nine Months Ended
September 30, September 30,
($ million, except per share)   2014   2013     2014   2013
Reported Net Income 52 80 165 202
Subtract: Estimated Net Income, Vectrus Operations   2   24     22   84
Estimated Net Income, Stand-alone Exelis   50   56     143   118
                   
Separation costs for the Vectrus spin-off, net of tax 9 - 19 -
Subtract: Separation costs, Vectrus Operations   8   -     15   -
Separation costs, Stand-alone Exelis   1   -     4   -
                   
Adjusted Net Income 61 80 184 202
Subtract: Estimated Adjusted Net Income, Vectrus Operations   10   24     37   84
Estimated Adjusted Net Income, Stand-alone Exelis   51   56     147   118
                   
Net Income per fully diluted share 0.27 0.41 0.85 1.06
Subtract: Estimated Net Income per fully diluted share, Vectrus Operations   0.01   0.13     0.11   0.44
Estimated Net Income per fully diluted share, Stand-alone Exelis   0.26   0.29     0.74   0.62
                   
Adjusted Net Income per fully diluted share 0.32 0.41 0.95 1.06
Subtract: Estimated Adjusted net Income per fully diluted share, Vectrus Operations   0.06   0.13     0.19   0.44
Estimated Adjusted Net Income per fully diluted share, Stand-alone Exelis   0.26   0.29     0.76   0.62
 
Weighted Average Shares Outstanding, Diluted 193.2 192.8 193.9 191
 

                 
Exelis Inc.
Non-GAAP Financial Measures - Adjusted Net Income & Adjusted EPS Excluding Vectrus Results
 
 
 
Three Months Ended Three Months Ended

September 30, 2014

September 30, 2013

Estimated

Separation Costs

Estimated

Estimated

Separation Costs

Estimated
Vectrus Stand-alone

Stand-alone

Vectrus Stand-alone Stand-alone
($ million)   As Reported   Operations   Exelis  

Exelis

As Reported   Operations   Exelis   Exelis
Orders 1,544 (686 ) 858 1,969 (922 ) 1,047
C4ISR 437 437 540 540
I&TS   1,107     (686 )       421   1,429     (922 )       507  
                               
Sales 1,068 (288 ) 780 1,141 (346 ) 795
C4ISR 503 503 498 498
I&TS   565     (288 )       277   643     (346 )       297  
                               
Operating Income 96 (2 ) 2 96 133 (32 ) 101
C4ISR 59 1 60 69 (2 ) 67
I&TS   37     (2 )   1   36   64     (30 )       34  
                               
Operating Margin 9.0 % 12.3 % 11.7 % 12.7 %
C4ISR 11.7 % 11.9 % 13.9 % 13.5 %
I&TS   6.5 %           13.0 % 10.0 %           11.4 %
                               
 
Cash Flow from Operating Activities 49 (35 ) 2 16 74 (12 ) 62
Subtract: Capital Expenditures   (19 )   -         (19 ) (20 )   -         (20 )
Free Cash Flow   30     (35 )   2   (3 ) 54     (12 )   -   42  
 



Contact:

Exelis
Investors
Katy Herr, 703-790-6376
Email Contact
or
Media
B.J. Talley, 703-790-6349
Email Contact